Safety First

Prescribing for Co-Morbidities Non Medical Prescribing Update Training

Up to 35 delegates

The Course Aim

To update participants in relation to potential issues associated with prescribing for co-morbidities to improve safe and effective prescribing.

Learning outcomes

By the end of the session participants will have an increased understanding of:

• The classification of adverse drug reactions and interactions and how they occur
• The physiological changes which occur in the elderly and how these might impact on drug handling
• The significance of drug interactions with particular respect to elderly
• The nature of polypharmacy and the groups of patients most affected
• The factors which result in polypharmacy and how they may be avoided
• Undertaking a medication review

Course content

This update will utilise lectures and small group work to enhance participant understanding of what drug interactions are, why they occur and their impact on elderly patients.

Trainers

Denise Rabbette registered as a Pharmacist in 1996.  After completing a clinical diploma and moving into primary care and community services, she supported the Metropolitan Police to develop PGDs for use by nurses in custody suites before accepting a position as the Head of Medicines Management where she developed a support structure for Non-Medical Prescribers and embedded protected time in the workplace for reflective practice.  In 2006 she emigrated to Egypt and worked as the healthcare correspondent for ‘Sharm Reality Magazine’ which was a lifestyle magazine intended for tourists and the ex-patriate population.  On her return to the UK she took a position as a QoF assessor and PRIMIS facilitator and worked within Care Homes to reduce anticholinergic burden, reducing the use of antipsychotics and deprescribing.  In 2015 she qualified as a prescriber and this led to the development of clinics for pain and atrial fibrillation management within GP practices. This opportunity then led to a position as an associate lecturer at the Medway School of Pharmacy.  In 2016 she returned to a role as the Head of Medicines Optimisation taking responsibility for ensuring that the CCG commissions pathways and treatments that have clinical and cost effectiveness at their heart. Medicines Optimisation is about ensuring people get the right choice of medicines, at the right time, and are engaged in the process by their clinical team. As the clinical lead for medicines safety deprescribing and antimicrobial stewardship are high on the agenda and is now being driven by the WHO medication without harm campaign.